SCHEMBL8329692

SCHEMBL8329692

CCOC(=O)C(OC)(C(=O)O)C1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.42
GPR119 Q8TDV5 4/20 0.41
RECQL P46063 1/20 0.40
EPHX1 P07099 1/20 0.40
EED O75530 1/20 0.40
RBBP4 Q09028 1/20 0.40
SUZ12 Q15022 1/20 0.40
EZH2 Q15910 1/20 0.40
AEBP2 Q6ZN18 1/20 0.40
KDM4E B2RXH2 1/20 0.40
PKM P14618 1/20 0.40
GAA P10253 2/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
ALDH1A1 P00352 3/20 0.39
LMNA P02545 2/20 0.39
TSHR P16473 1/20 0.39
THRB P10828 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
USP2 O75604 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8329687 0.94 GPR119 (0.45) HPGDGPR119RECQLEPHX1EED
SCHEMBL19995830 0.81 HPGD (0.48) HPGDGPR119RECQLEPHX1KDM4E
SCHEMBL30659463 0.79 HPGD (0.46) HPGDGPR119RECQLEPHX1KDM4E
SCHEMBL28577166 0.77 RECQL (0.44) HPGDGPR119RECQLEPHX1KDM4E
SCHEMBL8329830 0.77 CHRM2 (0.37) RECQLKDM4EPKMGAAMEN1
SCHEMBL22680078 0.76 GAA (0.43) HPGDGPR119RECQLEPHX1GAA
SCHEMBL22680079 0.76 GAA (0.43) HPGDGPR119RECQLEPHX1GAA
SCHEMBL22680073 0.76 GAA (0.43) HPGDGPR119RECQLEPHX1GAA
SCHEMBL7141622 0.74 HPGD (0.49) HPGDGPR119RECQLEPHX1KDM4E
SCHEMBL8333352 0.74 TSHR (0.36) HPGDRECQLGAAKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5908863-A ANTIGROWTH AGENT FOR BONES DOMPE' S.P.A. (IT) 1999-06-01 US disclosed
EP-0792878-A2 Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism Dompé S.P.A. (IT) 1997-09-03 EP disclosed